Joshua Fein (@joshuaafein) 's Twitter Profile
Joshua Fein

@joshuaafein

Weill-Cornell hem/onc fellow; interested in big data and small data in acute leukemia and allo transplant; dad to 3 very silly kids

ID: 89023598

calendar_today10-11-2009 21:16:21

2,2K Tweet

890 Takipçi

1,1K Takip Edilen

Priyanka Pophali, MD (@priyankapophali) 's Twitter Profile Photo

Thanks manalikamdar for your insightful commentary on our CIBMTR study looking at outcomes of CD19 #CART in THRLBCL! It was great collaborating with Joshua Fein Mazyar Shadman, MD MPH Roni Shouval Mehdi Hamadani, MD on this study! ashpublications.org/bloodadvances/…

ASH (@ash_hematology) 's Twitter Profile Photo

What will be your hematology success story? Apply for research funding and mentorship for #MedicalStudents #Residents and #DoctoralStudents. Learn more about these awards: ow.ly/zHCB50TujAe #ASHTrainee

What will be your hematology success story? Apply for research funding and mentorship for #MedicalStudents #Residents and #DoctoralStudents.
 
Learn more about these awards: ow.ly/zHCB50TujAe #ASHTrainee
Joshua Fein (@joshuaafein) 's Twitter Profile Photo

October 31, 2024: 1-1 'Commensal organisms...' some nice little monster organisms for Halloween! open.substack.com/pub/janewaypag…

October 31, 2024: 1-1 'Commensal organisms...' some nice little monster organisms for Halloween!

open.substack.com/pub/janewaypag…
Blood Journal (@bloodjournal) 's Twitter Profile Photo

Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS ow.ly/GRZg50TNQrV #immunobiologyandimmunotherapy #transplantation

Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS 
ow.ly/GRZg50TNQrV #immunobiologyandimmunotherapy #transplantation
Bryan Behar (@bryanbehar) 's Twitter Profile Photo

Donald Trump is everything we were ever taught was wrong. This feels like more than an election. It’s a referendum on whether being good or decent even matters any more.

Blood Advances (@bloodadvances) 's Twitter Profile Photo

The 2-year progression-free survival of 58 patients with T-cell/histiocyte–rich large B-cell lymphoma treated with CD19-CART therapy was 29%. ow.ly/hvB450TRX1M #lymphoidneoplasia

The 2-year progression-free survival of 58 patients with T-cell/histiocyte–rich large B-cell lymphoma treated with CD19-CART therapy was 29%. ow.ly/hvB450TRX1M #lymphoidneoplasia
Joshua Fein (@joshuaafein) 's Twitter Profile Photo

Congrats on this impressive and important work! Exciting to see the benefit of collaboration across groups at multiple NY institutions. Justin Kaner

Teng Fei (@statfei) 's Twitter Profile Photo

Excited to share our R package for microbiome data analysis, published Cell Reports Methods, which makes log-ratio lasso regression more accessible for R users, supporting continuous, binary and survival (competing risks) outcomes. github.com/vdblab/FLORAL doi.org/10.1016/j.crme…

Excited to share our R package for microbiome data analysis, published <a href="/CellRepMethods/">Cell Reports Methods</a>, which makes log-ratio lasso regression more accessible for R users, supporting continuous, binary and survival (competing risks) outcomes.
github.com/vdblab/FLORAL
doi.org/10.1016/j.crme…
Weill Cornell BMT Program (@weillcornellbmt) 's Twitter Profile Photo

Applications for the 2026 Weill Cornell Medicine NewYork-Presbyterian advanced Bone Marrow Transplant (#BMT) and #CellularTherapy fellowship are open. Apply for the opportunity to join our team in July 2026: bit.ly/3JkgMFu

Applications for the 2026 <a href="/WeillCornell/">Weill Cornell Medicine</a> <a href="/nyphospital/">NewYork-Presbyterian</a> advanced Bone Marrow Transplant (#BMT) and #CellularTherapy fellowship are open. Apply for the opportunity to join our team in July 2026: bit.ly/3JkgMFu